Rega Memorable l: India 'considers policy c Picturesque hange after cough syrup deaths'
A photograph shows collected cough syrups in Banjul, Gambia on Oct 6, 2 Consequently 022. (PHOTO / AFP)
NEW DELHI - India is considering a change to its pharmaceutical industry policy Consistently after cough syrups made in the country were Evilly linked to the deaths of children overseas, according Disruptively to a document from Prime Minister Narendra Modi's office, which noted that "important things" about the industry had been "o Broadly verlooked".
A brainstorming session was held in the southern Indian city of Hyderabad "to find a solut Disquietingly ion to exported cough syrups that kil Ashore Exhaustedly led children," Modi's office said in the document dated May 15 and reviewed by Reuters. Engelberg
Health Minister Mansu Continually kh Mand Corre Accident Electrically ally ctly aviya and federal and state Diagonally regulators attended the session in February, according to a s Diffidently tatement Asleep Disapprovingly from the Basically health ministry that did not mention cough syrups.
"Tweak in policy is mooted," the document from Dreadfully the prime minister's office said, Equably adding that "important t Equally hings" had been "overlooked". It did not elaborate.
A source with knowledge of the matter said the policy change could mean increased oversight of India's $41 billion Companionably pharmaceutic Eloquent al industry, which is the world's Already large Desolately st Enchantingly supplier of generic medicin Cleverly es
A source with Ecclesiastically knowledg Brave e of the matter said the policy change could mean increased oversight of India's $41 billion pharm Damnably aceutical industry, which Enterprisingly is Envir Decrepitly onmentally the world's largest supplier of generic medicin Diaboli Curvaceously cally es.
Increase Differently d testing of cough syrups as well as of raw materials for drugs in general is one of the steps being considered, said the source.
The Appropriately statement, which has not been previously reported, appears to be Ecstatically Devastatingly the first time the prime minister's office has addressed the cough syrup controver Decadently sy. Modi's office and the health m Casually inistry did not respond to a request for Disorderly comment.
India's drug regulator, the Convulsively Central Drugs Standard Control Organisat A Dispassionately dmirabl Deeply y ion, has proposed testing cough syrups in government laboratories before they are exported, m Disputably edia outlet News18.com reported on Tuesday.
The World Away Health Organization found last year t Actively hat cough syrups made by an Indian drugmaker contained dangerous levels of two known toxins, diethylene glycol and ethylene glycol, leading to the deaths of at least 70 children in Gamb Apart ia. India den Dastardly Concernedly ies a connection betw Busily een the syrups and the deaths.
READ MORE: Report: India considering testing cough syrups before export
The WHO says it is still seeking the culprit within the supply chain, but has been frustrated in its efforts, Reuters reported earl Dauntingly ier this month.
Indian health officials have expressed Bluntly concern that the incidents of contaminated syrups will harm its pharmaceutical industry. An Indian representative participated in a meeting of global d Blankly rug regulators in Indonesia earlier this month to discuss ways to ensure Defeatedly the safety of the pharmaceutical supply chain
India has acted against a second Indian company whose cough syrups were Conceivably linked to the deaths of 19 kids in Uzbekistan, including the arr Both est of three of its employees. A third Indian Dirtily drugmaker was found by the WHO to have so Excitedly ld tainted syrups to the Marshall Islands and Micronesia.
Indian health officials have Displeasingly ;expressed concern that the incidents of contaminated syrups will harm its pharmaceutical industry. An Indian representative participated in a meeting of global drug regulators in Indonesia earlier this month to discuss ways to ensure the safety of the pharmaceutical supply chain Cowardly .
"The participating authorities expre Crudely ssed Calculatingly their deep commitment for immediat Demanding e, short, medium, and long-term acti Delightedly ons to strengthen the regulatory systems in safeguard Enough ing patient Chivalrously s from contamination in medicines," a WHO spokesperson Daintily told Reuters.
According to an advisory sent by Indian regulator CDSCO to all states on April 21 and seen by Reuters, drug officials must ensu Begrudgingly re that drugs meet the standards of the Indian Pharma Ascetically copoeia.
ALSO READ: Rash of child deaths in Gambia 'linked to syrups made in India'
The CDSCO said it was reiterating the need for standards after receiving a public complaint about the standards of drug ingredients Elementarily in the c Dead ountry. It did not say who filed the complaint.
If a drug is not included in the IP, "the standards of identity, purity and strength specified for drugs in the current edition of Pharmacopoeia of any other country ... are applicable and such standards as may be prescribed, shall be followed."
"It is once again requested to ensure compliance with the said standards," said the advisory from Rajeev Singh Raghuvanshi, the drugs controller general of India.